What medications can be used to lower estrogen levels in men undergoing testosterone therapy?

Aromatase Inhibitors Are Used to Lower Estrogen in Men on Testosterone Therapy

Men on testosterone therapy who develop elevated estrogen levels are typically treated with aromatase inhibitors, most commonly anastrozole, though this is an off-label use not specifically addressed in major clinical practice guidelines. The Endocrine Society and AUA guidelines for testosterone therapy do not recommend routine estrogen monitoring or management in most men 1, 2, 3.

The Clinical Context

The major clinical practice guidelines focus on monitoring testosterone levels, hematocrit, PSA, and prostate health during testosterone therapy, but do not provide specific recommendations for managing elevated estrogen levels 1, 2, 1, 2, 1. This represents a significant gap between guideline recommendations and actual clinical practice.

When Estrogen Management Is Considered

For Men Desiring Fertility

The 2018 AUA guideline explicitly states that clinicians may use aromatase inhibitors, human chorionic gonadotropin (hCG), selective estrogen receptor modulators (SERMs), or combinations thereof in men with testosterone deficiency who desire to maintain fertility 3. This is a conditional recommendation with Grade C evidence. These agents work by promoting endogenous testosterone production rather than suppressing estrogen in men already on exogenous testosterone.

For Men Already on Testosterone Therapy

In actual clinical practice (though not guideline-endorsed):

• Aromatase inhibitors are used when estradiol levels exceed 60 pg/mL regardless of symptoms, or 40-60 pg/mL with symptoms 4
• Common symptoms prompting treatment include gynecomastia, mood changes, and sexual dysfunction
• Anastrozole is the most commonly prescribed agent, typically at doses ranging from 0.5 mg three times weekly to 1 mg daily, though significant variability exists in prescribing patterns 4, 5

Evidence from Clinical Practice

Recent research demonstrates:

• Only 3% of men on testosterone therapy required aromatase inhibitor treatment for elevated estrogen in one large practice 4
• Anastrozole effectively reduces estradiol levels from median 65 pg/mL to 22 pg/mL while maintaining testosterone levels 4
• Men on intramuscular testosterone are more likely to develop elevated estrogen requiring treatment compared to topical formulations 4
• Approximately 50-62% of practitioners monitor estrogen levels in men on testosterone therapy, with significant practice variation 5

Important Caveats and Pitfalls

Lack of Guideline Support

The use of aromatase inhibitors to manage estrogen in men on testosterone therapy is not endorsed by major guidelines 1, 2, 3. This is empirical, off-label practice based on clinical experience rather than high-quality evidence.

Safety Concerns

• Aromatase inhibitors carry risks including increased thromboembolic disease, potential negative effects on bone mineral density, and impacts on sexual function 6
• Only hCG is FDA-approved for use in males among the fertility-preserving alternatives 3
• Long-term safety data for aromatase inhibitors in men is lacking

Measurement Challenges

• Significant variability exists in estradiol assay techniques and timing
• No consensus exists on optimal testosterone:estradiol ratios, though ranges of 10-30 (testosterone in ng/dL / estradiol in pg/mL) are suggested 7, 8
• The clinical significance of elevated estradiol in asymptomatic men remains unclear 9

Practical Approach When Estrogen Management Is Considered

If managing elevated estrogen in a symptomatic man on testosterone therapy:

1. Verify elevated estradiol with repeat testing (>60 pg/mL or >40 pg/mL with symptoms)
2. Consider dose reduction or formulation change of testosterone first
3. If aromatase inhibitor is used: Anastrozole 0.5 mg three times weekly is a common starting dose 4
4. Monitor both testosterone and estradiol levels to ensure testosterone remains therapeutic while estradiol decreases
5. Reassess need for continued therapy once estradiol normalizes

Alternative: SERMs

Selective estrogen receptor modulators (clomiphene, tamoxifen) are mentioned as alternatives, particularly in the fertility context, but are less commonly used for estrogen management in men already on exogenous testosterone 6, 3.

The Bottom Line

While aromatase inhibitors (primarily anastrozole) are used in clinical practice to lower estrogen in men on testosterone therapy, this approach lacks strong guideline support and should be reserved for symptomatic men with documented elevated estradiol levels after considering testosterone dose adjustment. The decision to use these agents must weigh uncertain benefits against known risks, particularly in older men or those with cardiovascular risk factors.